Key points are not available for this paper at this time.
Abstract Fungal pathogens are a growing threat to public health. As human immunodeficiency becomes increasingly common, fungal infections are becoming more prevalent. The use of antifungal agents for prophylaxis and treatment of fungal infections has favored the emergence of previously rare or unidentified species of drug‐resistant fungal pathogens, including several Candida and Cryptococcus species, as well as mold pathogens. As these new and increasingly drug‐resistant fungal pathogens continue to emerge, novel strategies for rapid identification and treatment are necessary to combat these life‐threatening infections.
Geddes‐McAlister et al. (Tue,) studied this question.